Amgen Inc. discovers, develops, manufactures and delivers innovative human therapeutics worldwide, focusing on biotechnology to treat serious illnesses in oncology, inflammation, cardiovascular disease, bone health, nephrology, neuroscience…
HQ: Thousand Oaks, CA, United States of Americawww.amgen.com
USD465.67-0.30%vs prev. close
Performance
1W
+1.14%
1M
+9.28%
3M
+12.15%
1Y
+38.59%
YTD
+42.27%
Valuation
P/E
27.1
EPS TTM
17.20
Dividend yield
2.16%
Size and risk
Market cap
$251.9B
Beta
0.42
Price history
AMGN price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Amgen
AMGN
Drug Manufacturers - General
Mkt cap (USD bn)
251.9
P/E
27.1
Div yld
2.16%
1W
+1.1%
1M
+9.3%
3M
+12.2%
6M
+42.7%
1Y
+38.6%
YTD
+42.3%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Amgen
AMGN
Drug Manufacturers - General
251.9
27.1
2.16%
+1.1%
+9.3%
+12.2%
+42.7%
+38.6%
+42.3%
Subscribe to Equity Analytics to compare AMGN with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.